Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) had Normalized Income after Taxes of $-7.02M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$10.96M |
|
$-7.02M |
|
$1.99M |
|
$8.97M |
|
$18.47M |
|
$-7.51M |
|
$0.49M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
|
Normalized Income after Taxes |
$-7.02M |
$-7.51M |
|
$-6.41M |
|
11.39M |
|
11.39M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$28.02M |
|
$2.79M |
|
$6.10M |
|
$34.13M |
|
$3.25M |
|
-- |
|
$2.54M |
|
$5.79M |
|
$28.34M |
|
$28.15M |
|
$28.34M |
|
11.45M |
|
| Cash Flow Statement Financials | |
$-2.76M |
|
$-1.16M |
|
$1.11M |
|
$29.86M |
|
$26.67M |
|
$-3.19M |
|
$1.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
81.83% |
|
-68.55% |
|
-68.55% |
|
-58.49% |
|
-64.05% |
|
-64.05% |
|
$-3.65M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
2.79 |
|
27.89 |
|
13.09 |
|
-24.77% |
|
-24.93% |
|
-20.57% |
|
-24.77% |
|
$2.47 |
|
$-0.32 |
|
$-0.24 |
|